DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 18, 2022 | $87,644 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 24, 2023 | $87,644 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Law Enforcement/Crime/Criminal Justice LAW
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
| Lobbyist | Covered position, as disclosed |
|---|---|
| QUEEN ABIMBOLA ADESUYI | — |
| MICHAEL LISZEWSKI New | — |
| MARITZA PEREZ MEDINA New | — |
Budget/Appropriations BUD
Lobbied for $69.5 million in appropriations for syringe service programs and other harm reduction tools/services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARITZA PEREZ MEDINA New | — |
| GRANT SMITH | — |
Health Issues HCR
Lobbied for $69.5 million appropriations funding for syringe service providers and to lift the federal ban on syringes. Lobbying to pass a fentanyl harm reduction bill called the STOP Fentanyl Act (HR 2366/S 1457) which emphasizes expanding access to health services for people who use drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARITZA PEREZ MEDINA | — |
| GRANT SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.